🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New ASCO clinical guidelines on salivary gland cancers, co-authored by ACCRF founder Marnie Kaufman ascopubs.org/doi/full/10.12…

Phase II results of ATRA for #ACC now available. Some stabilizing effect in prior VEGFR treated and low MYB expressers. Waiting for ATRA+apatinib data ASCO 🧐🔎Dr. Len Zon @HNOPDFCI DanaFarber_HeadNeck Dana-Farber News ACCRF Salivary Gland Cancer | Charity ACC Research authors.elsevier.com/a/1dAmA4tFDICS…

Journal of Clinical Oncology has published a new guidelines for “Management of Salivary Gland Malignancy” including #adenoidcysticcarcinoma at ascopubs.org/doi/full/10.12…. Congratulations to the co-authors, including ACCR Foundation ’s Marnie Kaufman

New ACCRF Update on Leadership, Treatment Guidelines, Clinical Trials, Research Priorities and #AttackACC Dodgeball Challenge conta.cc/3qFnL2t

Perhaps we need to think about Notch pathway targeting even in the absence of a NOTCH mutational status in ACC? 🧐🧬🔍👀 Alan Ho Jeff Kaufman ACCRF @CellestiaBio @AccoiOrg oncologypro.esmo.org/meeting-resour…

ACCRF is working hard to bring new and better treatments for ACC patients. There are new clinical trials open in ACC in United States and abroad...for full and current list, please check out: accrf.org/treatments/cli…

If you are ACC patient, want to help advance research in ACC and have an upcoming surgery, here is an opportunity to donate tumor/tissue sample: accrf.org/living-with-ac…

ACCRF community research update recording from Nov 6, 2021 virtual meeting: vimeo.com/648844721

On 2/24/22 from 10am to 10pm (EST), we're raising money for ACCRF in memory of my dad, who died from ACC on 2/24/20. Can't tell y'all how important this is to me, please tell your friends and come hang with me next Thursday. (fundraiser link below) twitch.tv/xavcharlie

Developing new tools to find better treatments for ACC patients #adenoidcysticcarcinoma #kiyatec businesswire.com/news/home/2022…

ACC Patient Webinar, 5K and Fundraisers! conta.cc/3EUllUv

Congrats to Columbia Stem Cell Initiative (CSCI) Herbert Irving Comprehensive Cancer Center PhD student Sara Viragova (Dalerba lab) awarded the 1st prize for Early Career Scientists by Jed Ian Taxel Foundation for Rare Cancer Research for her work on inhibitors of retinoid signaling as anti-tumor agents in Adenoid Cystic Carcinoma #cancer

New webinar, board member and clinical trials: conta.cc/3wuKlz9

ACCRF awarded the 2022 Kara Gelb Memorial Grant to Dr. Maxim Pimkin of Dana-Farber to study targeted protein degradation of MYB in ACC”, with the goal of finding better treatments. accrf.org/research/grant…

A fine multi-institutional research effort by #ACCRF grantees and collaborators at #MDAnderson, #UCCancerCenter, #BrighamWomens and #AyalaPharma pubmed.ncbi.nlm.nih.gov/35931701/

Fascinating article on different perspectives from surgeons on resecting primary lung cancers...likely relevant to ACC lung metastases as well statnews.com/2022/09/23/sur…

In 2016, the lab of ACCRF grantee Dr. Brad Bernstein identified the translocation mechanism by which the MYB gene drives ACC tumors. This week, he and his colleagues published on how two populations of ACC tumor cells communicate with each other pubmed.ncbi.nlm.nih.gov/36450256/

The latest ACCRF email update covers an upcoming patient webinar, a research video, trial updates and treatment articles conta.cc/3DMLzch

ACCRF Patient Webinar on "Dealing with ACC Lung Mets" with medical oncologist Dr. Renata Ferrarotto (MD Anderson) and radiation oncologist Dr. Jonathan Schoenfeld (Dana Farber) accrf.org/about-accrf/pa…

New research published in JNCI by Piero Dalerba, MD, and his team examines the distinct vulnerabilities of two types of tumor cells present in adenoid cystic carcinoma, a rare but deadly form of cancer. Research supported by ACCRF Learn more: academic.oup.com/jnci/advance-a…